Connection
Amy Franks to Clinical Trials as Topic
This is a "connection" page, showing publications Amy Franks has written about Clinical Trials as Topic.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.169 |
|
|
|
-
Muldrew KM, Franks AM. Succinobucol: review of the metabolic, antiplatelet and cardiovascular effects. Expert Opin Investig Drugs. 2009 Apr; 18(4):531-9.
Score: 0.069
-
Franks AM, Gardner SF. AGI-1067: a novel vascular protectant for prevention of restenosis. Ann Pharmacother. 2006 Jan; 40(1):66-73.
Score: 0.055
-
Gardner SF, Franks AM. Olmesartan medoxomil: the seventh angiotensin receptor antagonist. Ann Pharmacother. 2003 Jan; 37(1):99-105.
Score: 0.045